Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips
Globus Medical, Inc. GMED reported fourth-quarter 2024 adjusted earnings per share (EPS) of 84 cents, which beat the Zacks Consensus Estimate by 10.5%. The figure increased 40% year over year. Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Globus Medical Q4, 2024 sales rise
Globus Medical saw fourth quarter net sales grow 6.6% year over year, and full year sales leapt 60.6%, according to financial results posted Feb. 20.
Globus Medical: Q4 Earnings Snapshot
Globus Medical expects full-year earnings in the range of $3.40 to $3.50 per share, with revenue in the range of $2.66 billion to $2.69 billion. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GMED at https://www.zacks.com/ap/GMED
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates
Globus Medical (GMED) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.60 per share a year ago. These figures are adjusted for non-recurring items.
BTIG Sticks to Its Buy Rating for Globus Medical (GMED)
In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price
Globus Medical (GMED) Q4 2024 Earnings Call Transcript
Operator Welcome to the Globus Medical's fourth quarter and full year 2024 earnings call. At this time, all lines will be on mute, and a Q&A session will be held after the prepared remarks. I will now turn the call over to Brian Kearns,
Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates
Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 billion,
MassDevice3h
Globus Medical beats Street in Q4, stock dips as analysts question Nevro buy
Globus Medical (NYSE:GMED) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.
Globus Medical: Q4 Revenue Tops Forecast
Medical technologies specialist Globus Medical ( GMED 0.04%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) ...
Globus Medical: Some Caution After Its Deal For Nevro
Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...
Yahoo Finance1mon
Globus Medical Surges 62.1% in a Year: What's Driving the Stock?
Globus Medical GMED has seen impressive momentum in the past year, with its shares soaring 62.1%. It has significantly outperformed the industry’s 7.3% rise and the S&P 500 composite’s 24.8% gain.
Nasdaq15d
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 Million
Globus Medical will acquire Nevro for $250 million in cash, enhancing its musculoskeletal technology portfolio andglobal marketreach. Globus Medical and Nevro Corp. have agreed on an all-cash ...
The Bakersfield Californian22d
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full ...